March 25 (Reuters) - Abbvie Inc ( ABBV ):

* ABBVIE TO ACQUIRE LANDOS BIOPHARMA, FURTHER STRENGTHENING

ITS

PORTFOLIO IN INFLAMMATORY AND AUTOIMMUNE DISEASES

* ABBVIE INC ( ABBV ) - UNDER TERMS OF AGREEMENT, ABBVIE WILL ACQUIRE

LANDOS AT A PRICE OF $20.42 PER SHARE IN CASH UPON CLOSING

* ABBVIE INC ( ABBV ) - PROPOSED TRANSACTION IS EXPECTED TO CLOSE IN

SECOND

CALENDAR QUARTER OF 2024

* ABBVIE-PROPOSED DEAL INCLUDES ONE NON-TRADABLE CONTINGENT

VALUE

RIGHT PER SHARE OF UP TO $11.14, OR ABOUT ADDITIONAL $75 MILLION

ON ACHIEVING SOME MILESTONES

Source text for Eikon:

Further company coverage: